Free Trial

AlloVir (ALVR) SEC Filings & 10K Form

AlloVir logo
$7.40 -0.67 (-8.30%)
As of 04/3/2025

Recent AlloVir SEC Filings

DateFilerForm TypeView
03/27/2025
6:19 PM
Hagen Brett R (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3/A
03/25/2025
6:38 PM
AlloVir (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/25/2025
6:40 PM
AlloVir (Subject)
Samsara BioCapital, L.P. (Filed by)
Form SCHEDULE 13D
03/20/2025
3:32 PM
GILEAD SCIENCES, INC. (Filed by)
AlloVir (Subject)
Form SCHEDULE 13G/A
03/18/2025
4:44 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:45 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:37 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:40 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:41 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:43 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:25 PM
Dybbs Michael (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:27 PM
Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:30 PM
AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:14 PM
ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:17 PM
Feinsod Matthew (Reporting)
AlloVir (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:20 PM
AlloVir (Issuer)
Oxtoby Andrew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:21 PM
AlloVir (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
4:04 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:18 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
6:30 AM
AlloVir (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
10:51 AM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:55 AM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
10:56 AM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
12:17 PM
AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
Form SCHEDULE 13G/A
02/10/2025
11:15 PM
AlloVir (Filer)
Form EFFECT
02/10/2025
3:19 PM
AlloVir (Filer)
Form 424B3
01/24/2025
1:51 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
1:55 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
2:03 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:39 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:41 PM
AlloVir (Subject)
Form 425
01/13/2025
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
6:44 AM
AlloVir (Subject)
Form 425
01/10/2025
6:42 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
3:21 PM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
12/20/2024
3:23 PM
AlloVir (Subject)
Form 425
12/11/2024
4:07 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
5:37 AM
AlloVir (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/06/2024
8:50 PM
AlloVir (Subject)
Form 425
12/06/2024
6:23 AM
AlloVir (Filer)
Form DEF 14A
11/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
3:05 PM
AlloVir (Subject)
Form 425
11/08/2024
3:06 PM
AlloVir (Subject)
Form 425
11/08/2024
3:09 PM
AlloVir (Subject)
Form 425
11/08/2024
3:10 PM
AlloVir (Subject)
Form 425
11/08/2024
7:26 AM
AlloVir (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:33 AM
AlloVir (Subject)
Form 425
11/05/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
10:14 AM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Hagen Brett R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump Treasure April 19 (Ad)

Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…

If I’m right about this (like I was before) a modest $900 investment…
08/19/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
7:00 PM
AlloVir (Subject)
Brainard Diana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
8:05 AM
AlloVir (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:15 PM
AlloVir (Issuer)
Hagen Brett R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Sinha Vikas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Brainard Diana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:15 PM
AlloVir (Issuer)
Miller Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
7:00 PM
AlloVir (Subject)
Miller Edward (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 PM
AlloVir (Subject)
Sinha Vikas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ALVR) was last updated on 4/5/2025 by MarketBeat.com Staff
From Our Partners